Sort   by:  
 Page size 
UnknownHER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations.
Not available
S-EPMC12294885 | biostudies-literature
UnknownDevelopment of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
Not available
S-EPMC10017935 | biostudies-literature
UnknownTargeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model.
Not available
S-EPMC7375560 | biostudies-literature
UnknownEvidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study.
Not available
S-EPMC8399332 | biostudies-literature
UnknownDistinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Not available
S-EPMC7027476 | biostudies-literature
UnknownAdjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Not available
S-EPMC10227592 | biostudies-literature
Sort   by:  
 Page size